News
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...
NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.
"It's criminal to put someone on a GLP-1 and not put them on a dietary plan," says Phil Vella, founder of Vita Bella Clinics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results